Emergency transfemoral aortic valve-in-valve implantation with the balloon-expandable Edwards–Sapien valve

2009 ◽  
Vol 10 (12) ◽  
pp. 936-939 ◽  
Author(s):  
Maurizio Taramasso ◽  
Francesco Maisano ◽  
Iassen Michev ◽  
Enrica Dorigo ◽  
Paolo Denti ◽  
...  
2020 ◽  
Vol 7 (12) ◽  
pp. 201838
Author(s):  
Romina Plitman Mayo ◽  
Halit Yaakobovich ◽  
Ariel Finkelstein ◽  
Shawn C. Shadden ◽  
Gil Marom

Leaflet thrombosis has been suggested as the reason for the reduced leaflet motion in cases of hypoattenuated leaflet thickening of bioprosthetic aortic valves. This work aimed to estimate the risk of leaflet thrombosis in two post-valve-in-valve (ViV) configurations, using five different numerical approaches. Realistic ViV configurations were calculated by modelling the deployments of the latest version of transcatheter aortic valve devices (Medtronic Evolut PRO, Edwards SAPIEN 3) in the surgical Sorin Mitroflow. Computational fluid dynamics simulations of blood flow followed the dry models. Lagrangian and Eulerian measures of near-wall stagnation were implemented by particle and concentration tracking, respectively, to estimate the thrombogenicity and to predict the risk locations. Most of the numerical approaches indicate a higher leaflet thrombosis risk in the Edwards SAPIEN 3 device because of its intra-annular implantation. The Eulerian approaches estimated high-risk locations in agreement with the wall sheer stress (WSS) separation points. On the other hand, the Lagrangian approaches predicted high-risk locations at the proximal regions of the leaflets matching the low WSS magnitude regions of both transcatheter aortic valve implantation models and reported clinical and experimental data. The proposed methods can help optimizing future designs of transcatheter aortic valves with minimal thrombotic risks.


2011 ◽  
Vol 79 (5) ◽  
pp. 733-740 ◽  
Author(s):  
Vinayak Bapat ◽  
Muhammed Z. Khawaja ◽  
Rizwan Attia ◽  
Ashok Narayana ◽  
Karen Wilson ◽  
...  

Circulation ◽  
2010 ◽  
Vol 121 (13) ◽  
pp. 1542-1543
Author(s):  
Rafael J. Ruiz-Salmerón ◽  
Omar Araji ◽  
Luis F. Valenzuela ◽  
Manuel Vizcaino ◽  
Antonio Fernández ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Siyamek Neragi-Miandoab ◽  
Robert E. Michler

Transcatheter aortic valve implantation (TAVI) has emerged for treating aortic stenosis in patients who are poor candidates for surgical aortic valve replacement. Currently, the balloon-expandable Edwards Sapien valve—which is usually implanted via a transfemoral or transapical approach—and the self-expanding CoreValve ReValving system—which is designed for retrograde application—are the most widely implanted valves worldwide. Although a promising approach for high-risk patients, the indication may be expanded to intermediate- and eventually low-risk patients in the future; however, doing so will require a better understanding of potential complications, risk factors for these complications, and strategies to individualize each patient to a different access route and a specific valve. This paper reviews the most relevant complications that may occur in patients who undergo catheter-based aortic valve implantation.


Sign in / Sign up

Export Citation Format

Share Document